You are here

  • Home
  • Online First
  • Comment on: Retrospective study of patient characteristics and treatment for mucormycosis in post-COVID-19 population

Article Text

Article menu
Download PDFPDF
Letter
Comment on: Retrospective study of patient characteristics and treatment for mucormycosis in post-COVID-19 population
  1. Hinpetch Daungsupawong1,
  2. Viroj Wiwanitkit2
  1. 1Private academic consultant, Phonhong, Lao People's Democratic Republic
  2. 2University Centre for Research and Development Department of Pharmaceutical Sciences, Chandigarh University, Mohali, Punjab, India
  1. Correspondence to Dr Hinpetch Daungsupawong; hinpetchdaung{at}gmail.com

https://doi.org/10.1136/ejhpharm-2024-004273

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the article ‘Retrospective study of patient characteristics and treatment for mucormycosis in post-COVID-19 population in a tertiary care hospital’ by Lakshmi et al.1 The purpose of their study was to investigate patient cases of mucormycosis that followed COVID-19 infection. In total they identified 33 cases, the majority being men with an average age of 55 years. According to their study, people …

    View Full Text

    Footnotes

    • HD and VW contributed equally.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.